Sheryl A. McCarthy

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

Michael K. Ahlijanian, Nestor X. Barrezueta, Robert D. Williams et al. · Proceedings of the National Academy of Sciences · 2000 · 335 citations

Molecular Biology, Cell Death, Cytoskeleton +20

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

C J Schmidt, Douglas S. Chapin, J. Cianfrogna et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 284 citations

Inhibition of the striatum-enriched phosphodiesterase PDE10A: A novel approach to the treatment of psychosis

Judith A. Siuciak, Douglas S. Chapin, John F. Harms et al. · Neuropharmacology · 2006 · 274 citations

Neuropsychology, Psychiatry, Psychotic Disorder +13

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function

Judith A. Siuciak, Sheryl A. McCarthy, Douglas S. Chapin et al. · Neuropharmacology · 2006 · 230 citations

Altered Striatal Function, Alzheimer's Disease, Molecular Neuroscience +9

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy et al. · Neuropharmacology · 2006 · 131 citations

Neuropsychology, Psychoactive Drug, Psychiatry +11